Market Tracker

11/21 6:05pm ET

ImmunoCellular Therapeutics Ltd (NYSE MKT LLC:IMUC)

0.6363
Data as of Nov 21
 -0.0137 / -2.11%
Today’s Change
0.53
Today|||52-Week Range
4.00
-31.21%
Year-to-Date
No recent news for ImmunoCellular Therapeutics Ltd.

Today’s Trading

Previous close0.65
Today’s open0.65
Day’s range0.62 - 0.65
Volume146,047
Average volume (3 months)386,721
Market cap$39.9M
Dividend yield--
Data as of 3:59pm ET, 11/21/2014

Growth & Valuation

Earnings growth (last year)+54.29%
Earnings growth (this year)-6.25%
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book1.38

Competitors

 Today’s
change
Today’s
% change
PBMDPrima BioMed Ltd-0.03-2.87%
--Protea Biosciences G...-0.03-5.88%
BCLIBrainstorm Cell Ther...+0.02+0.57%
AEZSAEterna Zentaris Inc+0.00+0.57%
Data as of 3:59pm ET, 11/21/2014

Financials

Last reporting dateNovember 10, 2014
EPS forecast (this quarter)-$0.03
Annual revenue (last year)$0.00
Annual profit (last year)-$8.8M
Net profit margin--

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, Secretary &
Chief Scientific Officer
John S. Yu
President, Chief Executive Officer &
Director
Andrew Gengos
Corporate headquarters
Calabasas, California

Forecasts